MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
暂无分享,去创建一个
Pei Yang | Wei Yan | Tao Jiang | Chuanbao Zhang | Zheng Wang | Zhaoshi Bao | T. Jiang | Z. Wang | Y. You | Yan-wei Liu | Chuanbao Zhang | Z. Bao | Wei Yan | Wei Zhang | Yanwei Liu | Wei Zhang | Yongping You | Rui Li | Rui Li | Pei Yang | Chuan-bao Zhang
[1] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[2] T. Mikkelsen,et al. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 , 2013, Oncotarget.
[3] Sujaya Srinivasan,et al. A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma , 2011, PloS one.
[4] Sun Mi Park,et al. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death , 2008, Oncogene.
[5] B. Jiang,et al. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma , 2014, Oncotarget.
[6] Jianguo Sun,et al. Cox Survival Analysis of Microarray Gene Expression Data Using Correlation Principal Component Regression , 2007, Statistical applications in genetics and molecular biology.
[7] Agnieszka Bronisz,et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.
[8] Kai Stühler,et al. Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas , 2010, Brain pathology.
[9] B. Tannous,et al. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis , 2010, Oncotarget.
[10] Fang Zhou,et al. A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis , 2011, Clinical Cancer Research.
[11] G. Kristiansen,et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma , 2009, International journal of cancer.
[12] Lei Han,et al. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. , 2012, Neuro-oncology.
[13] Junxia Zhang,et al. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.
[14] Satoshi O. Suzuki,et al. MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance , 2010, Clinical Cancer Research.
[15] Burton B. Yang,et al. Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 , 2012, Oncotarget.
[16] L. Deangelis. Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Dimos Kapetis,et al. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma , 2012, Oncotarget.
[18] S. Asuthkar,et al. Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity , 2012, Oncotarget.
[19] T. Mikkelsen,et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal , 2013, Oncotarget.
[20] Dong Wang,et al. Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets , 2010, PloS one.
[21] C. Croce,et al. MicroRNAs and chromosomal abnormalities in cancer cells , 2006, Oncogene.